Nanjing, China

Na Lu

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: China Pharmaceutical University. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Na Lu. Retrieved from https://idiyas.com/inventor/na-lu-au806o3t

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Na Lu - Innovator in Pharmaceutical Chemistry

Introduction

Na Lu is a prominent inventor based in Nanjing, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative research and development of medicinal compounds.

Latest Patents

Na Lu holds a patent related to a garcinia derivative, which is a structurally simplified analogue of the gambogic acid compound. This invention focuses on its preparation method and medicinal use, particularly in the development of anti-tumor drugs. The gambogic acid compound is known for its anti-cancer characteristics, making this patent a valuable addition to cancer treatment options.

Career Highlights

Na Lu is affiliated with China Pharmaceutical University, where he conducts his research and development activities. His work has garnered attention for its potential impact on pharmaceutical applications and cancer therapies.

Collaborations

Na Lu collaborates with esteemed colleagues, including Qidong You and Xiaojian Wang, who contribute to his research endeavors.

Conclusion

Na Lu's innovative work in pharmaceutical chemistry exemplifies the importance of research in developing effective treatments for cancer. His contributions continue to pave the way for advancements in medicinal chemistry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…